Cargando…

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

BACKGROUND: Patients with type II diabetes mellitus (DM) have an increased risk of adenomatous colorectal (CRC) polyps and CRC cancer. The use of the anti-hyperglycemic agent metformin is associated with a reduced incidence of cancer-related deaths. METHODS: We retrospectively evaluated the medical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garrett, C R, Hassabo, H M, Bhadkamkar, N A, Wen, S, Baladandayuthapani, V, Kee, B K, Eng, C, Hassan, M M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326682/ https://www.ncbi.nlm.nih.gov/pubmed/22421948 http://dx.doi.org/10.1038/bjc.2012.71

Ejemplares similares

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer
por: Al Omari, Amal, et al.
Publicado: (2018)

Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
por: Zanders, M M J, et al.
Publicado: (2015)

Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists
por: George, S, et al.
Publicado: (2006)

Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
por: Braghiroli, Maria Ignez, et al.
Publicado: (2015)

The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
por: Canna, K, et al.
Publicado: (2005)

METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
por: Glasberg, João, et al.
Publicado: (2022)

The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer
por: Richards, C H, et al.
Publicado: (2010)

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
por: Khan, O A, et al.
Publicado: (2008)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer
por: Ng, K, et al.
Publicado: (2009)

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer
por: Hoff, John, et al.
Publicado: (2014)

Effects of Metformin on the Cerebral Metabolic Changes in Type 2 Diabetic Patients
por: Huang, Yung-Cheng, et al.
Publicado: (2014)

Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
por: Gusella, M, et al.
Publicado: (2009)

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
por: Townsley, C A, et al.
Publicado: (2006)

The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands
por: Kilsdonk, M J, et al.
Publicado: (2014)

The effect of metformin on apoptosis in a breast cancer presurgical trial
por: Cazzaniga, M, et al.
Publicado: (2013)

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease
por: Lutgens, M W M D, et al.
Publicado: (2009)

Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer
por: Louvet, C., et al.
Publicado: (2010)

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
por: Saleh, Hend S., et al.
Publicado: (2016)

Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
por: Du, Xuan, et al.
Publicado: (2018)

Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients
por: Shioiri, M, et al.
Publicado: (2006)

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer
por: López, R, et al.
Publicado: (2010)

Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer
por: Yoshioka, T, et al.
Publicado: (2009)

Gallic acid improves the metformin effects on diabetic kidney disease in mice
por: Hong, Yan, et al.
Publicado: (2023)

Total Ossiculoplasty: Advantages of Two-Point Stabilization Technique
por: Berenholz, Leonard, et al.
Publicado: (2012)

Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?
por: Rakici, Halil, et al.
Publicado: (2015)

Drug interaction between hydroxychloroquine and metformin
Publicado: (2020)

Evaluation of Diabetic Patients with Breast Cancer Treated with Metformin during Adjuvant Radiotherapy
por: Ferro, Adam, et al.
Publicado: (2013)

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
por: Österlund, P, et al.
Publicado: (2011)

Observational Study on the Preparation of the Implant Site with Piezosurgery vs. Drill: Comparison between the Two Methods in terms of Postoperative Pain, Surgical Times, and Operational Advantages
por: Maglione, Michele, et al.
Publicado: (2019)

The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer
por: van Wyk, Hester C, et al.
Publicado: (2016)

Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
por: Wang, Yaodu, et al.
Publicado: (2017)

Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women
por: Coghill, A E, et al.
Publicado: (2011)

The relationship between patient physiology and cancer-specific survival following curative resection of colorectal cancer
por: Jenkins, J T, et al.
Publicado: (2007)

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer
por: Feliu, J, et al.
Publicado: (2005)

Timing of Exercise Affects Glycemic Control in Type 2 Diabetes Patients Treated with Metformin
por: Huang, Tao, et al.
Publicado: (2018)

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
por: Hoehler, T, et al.
Publicado: (2013)

Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with Metabolic Syndrome
por: Raub, Rebecca M., et al.
Publicado: (2012)

Do Pedicle Screws in Concave Apex of Scoliosis Offer Any Advantages?
por: Pithwa, Yogesh Kishorkant
Publicado: (2018)

Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
por: Joulain, F, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r2jdq4hrkbihv8nc5304nssvsp